Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Cefoxitin sodium
Drug ID BADD_D00394
Description Cefoxitin is a semi-synthetic, broad-spectrum cepha antibiotic for intravenous administration. It is derived from cephamycin C, which is produced by Streptomyces lactamdurans.
Indications and Usage For the treatment of serious infections caused by susceptible strains microorganisms.
Marketing Status approved
ATC Code J01DC01
DrugBank ID DB01331
KEGG ID D00913
MeSH ID D002440
PubChem ID 23667300
TTD Drug ID D02VFC
NDC Product Code 63323-342; 63323-341; 52946-0828; 0264-3123; 0264-3125
UNII Q68050H03T
Synonyms Cefoxitin | MK-306 | MK 306 | MK306 | Cefoxitin Sodium | Sodium, Cefoxitin | Mefoxin | Méfoxin | Mefoxitin
Chemical Information
Molecular Formula C16H16N3NaO7S2
CAS Registry Number 33564-30-6
SMILES COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Agranulocytosis01.02.03.001--Not Available
Alanine aminotransferase increased13.03.04.005--
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Angioedema23.04.01.001; 10.01.05.009; 22.04.02.008--Not Available
Aplastic anaemia01.03.03.002--Not Available
Aspartate aminotransferase increased13.03.04.011--
Blood bilirubin increased13.03.04.018--
Blood creatinine increased13.13.01.004--
Blood lactate dehydrogenase increased13.04.02.002--
Blood urea increased13.13.01.006--Not Available
Cholestasis09.01.01.001--Not Available
Colitis07.08.01.001--
Complications of transplanted liver12.02.09.014; 09.01.08.011--Not Available
Diarrhoea07.02.01.001--
Dyspnoea22.02.01.004; 02.11.05.003--
Eosinophilia01.02.04.001--
Erythema multiforme23.03.01.003; 10.01.03.015--
Flushing24.03.01.002; 08.01.03.025; 23.06.05.003--
Granulocytopenia01.02.03.003--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Hypotension24.06.03.002--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Leukopenia01.02.02.001--Not Available
Myasthenia gravis17.05.04.001; 15.05.08.001; 10.04.05.001--
Nausea07.01.07.001--
Nephropathy toxic20.05.03.002; 12.03.01.010--Not Available
Neutropenia01.02.03.004--Not Available
Pancytopenia01.03.03.003--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages